Fetal MRI-Calculated Total Lung Volumes in the Prediction of Short-Term Outcome in Giant Omphalocele: Preliminary FindingsDanzer E. · Victoria T. · Bebbington M.W. · Siegle J. · Rintoul N.E. · Johnson M.P. · Flake A.W. · Adzick N.S. · Hedrick H.L.
The Center for Fetal Diagnosis and Treatment, The Children’s Hospital of Philadelphia and The University of Pennsylvania School of Medicine, Philadelphia, Pa., USA
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Objective: To determine the value of fetal MRI-calculated total lung volumes (TLV) in the prediction of short-term outcome in patients with giant omphalocele (GO). Material and Methods: We reviewed all cases of GO undergoing fetal MRI after 21 weeks’ gestation and receiving postnatal care at our institution between 2003 and 2010. Observed/expected (O/E) TLV was calculated using age-matched TLV normograms [Radiology 2001;219:236–241]. Postnatal outcomes were stratified based on O/E TLV above or below 50% of expected. Results: Seventeen GO cases fulfilled the entry criteria. The mean age at fetal MRI evaluation was 25.8 ± 4.8 weeks’ gestation. The mean GO TLV (21.0 ± 13.2) was lower than age-matched population norms (p < 0.001), resulting in a mean O/E TLV of 52.3 ± 16.8%. The mean gestational age at delivery was 36.8 ± 1.6 weeks. Overall survival was 94%. Fourteen (88%) infants underwent staged reduction, and 2 underwent silver sulfadiazine treatment and delayed repair. Infants with ≤50% of predicted O/E TLV (n = 11, 65%) had lower Apgar scores at birth (p = 0.03), prolonged ventilatory support (p = 0.004), delayed oral intake (p = 0.03), and longer hospitalization (p = 0.03) compared to patients with ≥50% of expected O/E TLV. Two infants (both O/E TLV <50%) required tracheostomy placement. Conclusion: In the assessment of GO fetuses, MRI-based O/E TLV of <50% was predictive of increased postnatal morbidity.
© 2012 S. Karger AG, Basel
- Barisic I, Clementi M, Hausler M, Gjergja R, Kern J, Stoll C: Evaluation of prenatal ultrasound diagnosis of fetal abdominal wall defects by 19 European registries. Ultrasound Obstet Gynecol 2001;18:309–316.
- Biard JM, Wilson RD, Johnson MP, Hedrick HL, Schwarz U, Flake AW, Crombleholme TM, Adzick NS: Prenatally diagnosed giant omphaloceles: short- and long-term outcomes. Prenat Diagn 2004;24:434–439.
- Kamata S, Ishikawa S, Usui N, Kitayama Y, Sawai T, Okuyama H, Fukui Y, Kubota A, Imura K, Okada A: Prenatal diagnosis of abdominal wall defects and their prognosis. J Pediatr Surg 1996;31:267–271.
- Danzer E, Gerdes M, D’Agostino JA, Bernbaum J, Siegle J, Hoffman C, Rintoul NE, Liechty KW, Flake AW, Adzick NS, Hedrick HL: Prospective, interdisciplinary follow-up of children with prenatally diagnosed giant omphalocele: short-term neurodevelopmental outcome. J Pediatr Surg 2010;45:718–723.
- Mitanchez D, Walter-Nicolet E, Humblot A, Rousseau V, Revillon Y, Hubert P: Neonatal care in patients with giant omphalocele: arduous management but favorable outcomes. J Pediatr Surg 2010;45:1727–1733.
- Dunn JC, Fonkalsrud EW: Improved survival of infants with omphalocele. Am J Surg 1997;173:284–287.
- Loder RT, Guiboux JP: Musculoskeletal involvement in children with gastroschisis and omphalocele. J Pediatr Surg 1993;28:584–590.
- Paidas MJ, Crombleholme TM, Robertson FM: Prenatal diagnosis and management of the fetus with an abdominal wall defect. Semin Perinatol 1994;18:196–214.
- Kleinrouweler CE, Kuijper CF, van Zalen-Sprock MM, Mathijssen IB, Bilardo CM, Pajkrt E: Characteristics and outcome and the omphalocele circumference/abdominal circumference ratio in prenatally diagnosed fetal omphalocele. Fetal Diagn Ther 2011;30:60–69.
- Danzer E, Hubbard AM, Hedrick HL, Johnson MP, Wilson RD, Howell LJ, Flake AW, Adzick NS: Diagnosis and characterization of fetal sacrococcygeal teratoma with prenatal MRI. AJR Am J Roentgenol 2006;187:W350–W356.
- Hubbard AM, Adzick NS, Crombleholme TM, Coleman BG, Howell LJ, Haselgrove JC, Mahboubi S: Congenital chest lesions: diagnosis and characterization with prenatal MR imaging. Radiology 1999;212:43–48.
- Hubbard AM, Adzick NS, Crombleholme TM, Haselgrove JC: Left-sided congenital diaphragmatic hernia: value of prenatal MR imaging in preparation for fetal surgery. Radiology 1997;203:636–640.
- Hubbard AM, Crombleholme TM, Adzick NS: Prenatal MRI evaluation of giant neck masses in preparation for the fetal exit procedure. Am J Perinatol 1998;15:253–257.
- Gorincour G, Bouvenot J, Mourot MG, Sonigo P, Chaumoitre K, Garel C, Guibaud L, Rypens F, Avni F, Cassart M, Maugey-Laulom B, Bourliere-Najean B, Brunelle F, Durand C, Eurin D: Prenatal prognosis of congenital diaphragmatic hernia using magnetic resonance imaging measurement of fetal lung volume. Ultrasound Obstet Gynecol 2005;26:738–744.
- Paek BW, Coakley FV, Lu Y, Filly RA, Lopoo JB, Qayyum A, Harrison MR, Albanese CT: Congenital diaphragmatic hernia: prenatal evaluation with MR lung volumetry – preliminary experience. Radiology 2001;220:63–67.
- Sandaite I, Claus F, De Keyzer F, Done E, Van Mieghem T, Gucciardo L, DeKoninck P, Jani J, Cannie M, Deprest JA: Examining the relationship between the lung-to-head ratio measured on ultrasound and lung volumetry by magnetic resonance in fetuses with isolated congenital diaphragmatic hernia. Fetal Diagn Ther 2011;29:80–87.
- Cannie M, Jani J, Meersschaert J, Allegaert K, Done E, Marchal G, Deprest J, Dymarkowski S: Prenatal prediction of survival in isolated diaphragmatic hernia using observed to expected total fetal lung volume determined by magnetic resonance imaging based on either gestational age or fetal body volume. Ultrasound Obstet Gynecol 2008;32:633–639.
Hedrick HL, Danzer E, Merchant A, Bebbington MW, Zhao H, Flake AW, Johnson MP, Liechty KW, Howell LJ, Wilson RD, Adzick NS: Liver position and lung-to-head ratio for prediction of extracorporeal membrane oxygenation and survival in isolated left congenital diaphragmatic hernia. Am J Obstet Gynecol 2007;197:422e421–e424.
- Hedrick HL, Flake AW, Crombleholme TM, Howell LJ, Johnson MP, Wilson RD, Adzick NS: The ex utero intrapartum therapy procedure for high-risk fetal lung lesions. J Pediatr Surg 2005;40:1038–1043; discussion 1044.
- Rypens F, Metens T, Rocourt N, Sonigo P, Brunelle F, Quere MP, Guibaud L, Maugey-Laulom B, Durand C, Avni FE, Eurin D: Fetal lung volume: estimation at MR imaging – initial results. Radiology 2001;219:236–241.
- Baker PN, Johnson IR, Gowland PA, Freeman A, Adams V, Mansfield P: Estimation of fetal lung volume using echo-planar magnetic resonance imaging. Obstet Gynecol 1994;83:951–954.
- Kamata S, Usui N, Sawai T, Nose K, Fukuzawa M: Prenatal detection of pulmonary hypoplasia in giant omphalocele. Pediatr Surg Int 2008;24:107–111.
- Prendergast M, Rafferty GF, Davenport M, Persico N, Jani J, Nicolaides K, Greenough A: Three-dimensional ultrasound fetal lung volumes and infant respiratory outcome: a prospective observational study. BJOG 2011;118:608–614.
- Argyle JC: Pulmonary hypoplasia in infants with giant abdominal wall defects. Pediatr Pathol 1989;9:43–55.
- Hershenson MB, Brouillette RT, Klemka L, Raffensperger JD, Poznanski AK, Hunt CE: Respiratory insufficiency in newborns with abdominal wall defects. J Pediatr Surg 1985;20:348–353.
- Griscom NT, Driscoll SG: Radiography of stillborn fetuses and infants dying at birth. AJR Am J Roentgenol 1980;134:485–489.
- Dimitriou G, Greenough A, Kavvadia V, Davenport M, Nicolaides KH, Moxham J, Rafferty GF: Diaphragmatic function in infants with surgically corrected anomalies. Pediatr Res 2003;54:502–508.
- Cannie M, Jani JC, De Keyzer F, Devlieger R, Van Schoubroeck D, Witters I, Marchal G, Dymarkowski S, Deprest JA: Fetal body volume: use at MR imaging to quantify relative lung volume in fetuses suspected of having pulmonary hypoplasia. Radiology 2006;241:847–853.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.